Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC), ...

Optum Rx will increase reimbursements to pharmacies for brand-name drugs and cut them for generics.  Optum Rx said the new ...

KLOXXADO ® delivers 8 mg of naloxone hydrochloride per spray in a ready to use nasal spray to reverse the effects of opioid overdose.

UnitedHealth’s (NYSE:UNH) pharmacy benefit manager, Optum Rx, announced Thursday the launch of cost-based payment models to ...

OptumRx is changing the way it pays pharmacies, reimbursing them more for branded drugs and less for generics, the company ...

Amneal Pharmaceuticals, Inc. offers strong growth prospects with undervalued stock, rising revenues, reduced debt, and key ...

With Keytruda, the best-selling drug in the world, facing the end of exclusivity in 2028, BioSpace looks at five drugs that ...

Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, is offering a new suite of ...

A generic product cannot enter the market until the originator product’s IP has expired, but the development process can take ...

Victory Capital Management Inc. raised its position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Free Report) by 112.8% during the fourth quarter, HoldingsChannel.com reports. The firm owned 211,130 ...

Elizabeth Jones, MD, FAAD, Thomas Jefferson University Hospitals, highlights the continued relevance of older, generic dermatologic therapies despite the availability of newer, targeted treatments.